News results: "FDA panel" |
|
 |
|
FDA Extends Review of AstraZeneca, Bristol Diabetes Drug Onglyza
The Food and Drug Administration announced Thursday that it needs additional time to complete the...
|
Novo Still Hopeful on Diabetes Drug
Despite a split ruling on the safety of a new diabetes drug by the US Food and Drug...
|
FDA Panel Backs Bristol, AstraZeneca Diabetes Drug Onglyza
A federal panel of medical experts said Wednesday Bristol-Myers Squibb Co. and AstraZeneca...
|
US Panel Backs Roche’s Avastin for Brain Cancer
A panel of outside advisers to the Food and Drug Administration voted Tuesday in favor of Roche...
|
New Device Shows Promise in Treating Atrial Fibrillation
A new device implanted in the heart to stop blood clots from triggering strokes (from the rhythm...
|
FDA Panel Backs J&J, Bayer Anticlotting Drug
A panel of cardiology experts of the Food and Drug Administration voted 15 to 2 on Thursday in...
|
FDA Panel Backs Sanofi-Aventis’ Heart Drug for Approval
A panel of cardiology experts recommended Wednesday that Sanofi-Aventis experimental drug Multaq...
|
FDA to Ask Outside Panel about Extended Use of Seroquel
The Food and Drug Administration said Tuesday it will ask an outside panel of medical...
|
Lilly, Daiichi Blood Thinner Prasugrel Gets European Approval
The European Commission on Monday gave its approval for blood-thinning drug Efient for heart...
|
Depart. Of Justice Seeks Damages from J&J, Scios Unit
The US Justice Department on Thursday announced its intention to join two lawsuits against a unit...
|
Sanofi-Aventis Waits for FDA’s Decision on Multaq (Dronedarone) Heart Drug
The FDA is expected to take a decision regarding an experimental drug from Sanofi-Aventis which is...
|
Panel Unanimously Votes For Lilly, Daiichi Blood Thinner Prasugrel
An advisory panel of the US Food and Drug Administration on Tuesday voted unanimously to...
|
FDA Panel Backs Ely Lilly’s Blood Thinner Prasugrel
Blood thinner prasugrel, made by Eli Lilly and Co. in a joint with Daiichi Sankyo Co., Ltd., is...
|
Addictive Painkiller Finally Withdrawn by the FDA
An advisory panel to the Food and Drug Administration voted 14 to 12 to recommend the withdrawal of...
|
FDA Panel Votes to Ban Darvon Painkiller
Government advisers suggested a ban on the Darvon painkiller which has been in...
|
FDA: New Drug from Genetically Engineered Goats May Be on Its Way
The Food and Drug Administration revealed Wednesday that for the first time an anti-clotting drug...
|
FDA Panel Meeting For Reviewing Prasugrel
An FDA advisory panel will review the blood-cloth preventer prasugrel, according to maker Daiichi...
|
National Research Council asks EPA to Assess Phthalates
A panel from the independent National Research Council urged the U.S. Environmental...
|
FDA Criticized By Its Scientific Advisers In BPA Case
The Food and Drug Administration was recently
criticized by its own scientific advisers, and...
|
FDA Panel Rules: Two Popular Asthma Drugs Risky, Advair and Symbicort Safe
A Food and Drug Administration panel said Thursday that the risk of taking the asthma medications...
|
Advisory Panel Rules Advair Is Safe
A U.S. advisory panel ruled on Thursday that
GlaxoSmithKline Plc's widely prescribed drug Advair...
|
FDA Panel Calls for Restriction on Two Asthma Drugs
A US Food and Drug Administration panel decided on Thursday that two asthma drugs pose serious...
|
Harvard’s Renowned Psychiatrist under Investigation for Drug Earnings
A Congressional investigation led by Sen.
Charles Grassley revealed in June that a world-renowned...
|
FDA Panel Says Wrinkle Fillers Should Carry Stronger Warnings
Labels of popular cosmetic wrinkle fillers should carry
stronger warnings about potential side...
|
Insulin Syringes Recalled over Mislabeling and Overdose Risk
The US Food and Drug Administration is alerting doctors and
patients that Tyco Healthcare Group...
|
Update: FDA Needs To Reconsider Its Tolerance Regarding BPA
The FDA was urged by a scientific panel to rethink a recent conclusion that a chemical used in baby...
|
FDA Findings on BPA Safety Questioned Again by a Panel of Toxicologists
A panel of toxicology experts has urged the FDA to rethink its conclusions on bisphenol A, a...
|
Panel Questions FDA’s Report on BPA Safety
This week, a
scientific panel issued a report that questioned the Food and Drug
Administration’s...
|
Update: Panel Calls FDA Ruling On BPA “Inadequate”
Bisphenol A (BPA), the synthetic hormone used in baby
bottles, toddler cups, water bottle and...
|
Boost Your Way To The Hospital
As life gets busy and stressful from an earlier age than
fifty years ago, people are in desperate...
|
|
 |
Specials
|
Dundreon Shares Soar on Prostate Cancer Vaccine Success
Shares of Seattle-based Dendreon Corp. soared Tuesday on the news that its experimental vaccine for...
|
Device Prevents Stroke in Patients with Atrial Fibrillation
Researchers present Saturday at the American College of Cardiology Conference in Orlando, Florida...
|
FDA Advisory Panel Supports J&J, Bayer Anticlotting Drug Rivaroxaban
A Food and Drug Administration advisory panel voted on Thursday to recommend that the agency...
|
Daiichi, Lilly Get European Approval for Prasugrel
Monday, Eli Lilly & Company and Daiichi Sankyo Company announced that they had earned...
|
FDA Advisory Panel Recommends Banning Painkiller Darvon
FDA advisers have recommended that Darvon, a commonly prescribed painkiller, should be...
|
Are Popular Asthma Drugs Safe? FDA Panel to Decide on Their Safety
A Food and Drug Administration panel of medical
experts is weighing whether to allow certain...
|
FDA Advisory Panel Supports Approval Of Eyelash Fertilizer
An FDA advisory panel supported approval of
Latisse, a drug traditionally used to treat glaucoma,...
|
Panel Slashes FDA over Bisphenol Safety
A panel of environmental health, toxicology and statistics
experts from three major universities,...
|
Update: Report Seriously Questions FDA Ruling On BPA Safety
An expert panel asked by the Food and Drug Administration to
review its way of handling of the...
|
FDA Postpones Decision To Ban Kid’s Cough Medicine
The US Food and Drug Administration needs more data on whether over-the-counter
cold medicines are...
|
Eprex Under Close Scrutiny After German Trial Study
A Johnson & Johnson anemia drug tested in Germany on a panel of stroke patients is...
|
FDA Says Plastic Chemical Is Safe, Studies Claim It Poses Health Risks
A preliminary report by the FDA declared
the levels of bisphenol A (BPA) in baby bottles and other...
|
FDA Panel Recommends New Arthritis Drug Approval
An FDA panel voted Tuesday 10 to 1 for the approval of a new drug that fights against rheumatoid...
|
FDA Decides on Epilepsy Drug Situation
Although an advisory panel of the US Food and Drug
Administration said certain epilepsy drugs may...
|
FDA: J&J’s Psoriasis Drug Might Raise Cancer Risk
Johnson & Johnson’s experimental drug, ustekinumab appears
to be effective in treating...
|
|
 |
|
| Photos Gallery |
|
|
 |
|